Clinical Trial

IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary aim of this randomized trial is to assess the efficacy of IV Ferric Derisomaltose vs Oral Iron in the management of women with severe Iron Deficiency Anemia due to Uterine Bleeding in the emergency department.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-03-22; most recent amendment 2024-12-03.
Status change: Not Yet Recruiting → Recruiting 2023-02-06
Trial Details
NCT Number NCT05304442
Lead Sponsor Baylor College of Medicine
Collaborators: Pharmacosmos Therapeutics, Inc.
Conditions Anemia, Iron Deficiency, Uterine Bleeding
Enrollment 40 participants
Start Date 2022-09-15
Primary Completion 2025-03 (estimated)
Study Completion 2025-04 (estimated)
Updated on ClinicalTrials.gov 2024-12-05